A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Status: Recruiting
Location: See all (205) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on objective response rate (ORR) as assessed by blinded independent central review (BICR) according to the Response Evaluation Criteria in Solid Tumors and to compare the effect of SG to SOC on overall survival (OS).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Histologically confirmed diagnosis of SCLC.
• Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.
• Measurable disease by computed tomography (CT) or magnetic resonance imaging (MRI) as assessed by investigator per RECIST v1.1 criteria.
• Documentation of radiological disease progression after 1 prior line of platinum-containing chemotherapy (defined as at least 2 cycles of treatment) with or without therapy directed against programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PD-L1; PD-1 and PD-L1 are hereafter referred to as PD-(L)1) for ES-SCLC.
Locations
United States
California
Los Angeles Cancer Network
RECRUITING
Anaheim
Florida
Boca Raton Regional
RECRUITING
Miami
Illinois
Hope and Healing Cancer Services
RECRUITING
Hinsdale
Southern Illinois University School of Medicine
RECRUITING
Springfield
Springfield Clinic
RECRUITING
Springfield
Indiana
Parkview Research Center
RECRUITING
Fort Wayne
IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie
RECRUITING
Muncie
Kentucky
Northwest Cancer Centers
RECRUITING
Dyer
St. Claire Regional Medical Ce
RECRUITING
Morehead
New Mexico
New Mexico Oncology Hematology Consultants, Ltd
RECRUITING
Albuquerque
Ohio
University Hospitals Seidman Cancer Center
RECRUITING
Sandusky
Taylor Cancer Research Foundation
RECRUITING
Toledo
Pennsylvania
Spoknwrd Clinical Trials Inc.
RECRUITING
Easton
Texas
Hendrick Health System
RECRUITING
Abilene
MD Anderson Cancer Center
RECRUITING
Houston
Texas Oncology - San Antonio
RECRUITING
New Braunfels
The University of Texas Health Science Center at Tyler
RECRUITING
Tyler
Wisconsin
Gundersen Health System
RECRUITING
West Salem
Other Locations
Argentina
Clinica Colon S.A.A (Clinica y Maternidad Colon) Investigaciones Clinicas de Mar del Plata
RECRUITING
Buenos Aires
Hospital Britanico de Buenos Aires
RECRUITING
Buenos Aires
Universidad de Buenos Aires - Facultad de Medicina - Instituto Alexander Fleming (Buenos Aires)
RECRUITING
Buenos Aires
Centro Oncologico de Excelencia (San Juan)
RECRUITING
San Juan
Centro Médico San Roque
RECRUITING
San Miguel De Tucumán
Sanatorio Parque SA
RECRUITING
Santa Fe
Australia
Cancer Research SA
RECRUITING
Adelaide
St Vincent's Hospital Melbourne
RECRUITING
Fitzroy
Sir Charles Gairdner Hospital
RECRUITING
Nedlands
Cancer Care Wollongong
RECRUITING
New South Wales
Metro North HHS (The Prince Charles Hospital)
RECRUITING
Queensland
Gold Coast University Hospital
RECRUITING
Southport
Belgium
Grand Hopital de Charleroi
RECRUITING
Charleroi
Jessa Ziekenhuis
RECRUITING
Hasselt
Centre Hospitalier Universitaire de Liege Avenue de Lhopital 1
RECRUITING
Liège
AZ Delta
RECRUITING
Roeselare
Vitaz
RECRUITING
Sint-niklaas
Brazil
Instituto do Cancer do Ceara
RECRUITING
Fortaleza Ceara
Hospital de Caridade de Ijui
RECRUITING
Ijuí
Liga Norte-Rio-Grandense Contra o Cancer - Pesquisa Clinica
RECRUITING
Natal
Hospital Mae de Deus
RECRUITING
Porto Alegre
Hospital Sao Lucas da PUC Rio Grande do Sul
RECRUITING
Porto Alegre
IMIP - Instituto de Medicina Integral Professor Fernando Figueira
RECRUITING
Recife Pernambuco
Grupo Oncoclínicas
RECRUITING
Santa Lúcia
Centro de Estudos e Pesquisa de Hematologia e Oncologia
RECRUITING
Santo André
Fundação Pio XII - Hospital de Amor
RECRUITING
São Paulo
HB Onco
RECRUITING
São Paulo
Hospital Amaral Carvalho
RECRUITING
São Paulo
Instituto Hemomed Oncologia e Hematologia
RECRUITING
São Paulo
Canada
Royal Victoria Regional Health Centre
RECRUITING
Barrie
Hamilton Health Sciences - Juravinski Cancer Centre
RECRUITING
Hamilton
McGill University
RECRUITING
Montreal
CISSS BSL / Hopital regional de Rimouski
RECRUITING
Rimouski
Sunnybrook Health Sciences Centre
RECRUITING
Toronto
China
Beijing Cancer Hospital
RECRUITING
Beijing
Jilin Cancer Hospital
RECRUITING
Changchun
Sichuan Cancer Hospital
RECRUITING
Chengdu
Chongqing University Cancer Hospital
RECRUITING
Chongqing
Fujian Medical University Union Hospital
RECRUITING
Fuzhou
Sun Yat-sen University Cancer Center
RECRUITING
Guangzhou
The First Affiliated Hospital, Sun Yat-sen University
RECRUITING
Guangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
RECRUITING
Hangzhou
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING
Hangzhou
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITING
Hangzhou
Zhejiang Cancer Hospital
RECRUITING
Hangzhou
Harbin Medical University Cancer Hospital
RECRUITING
Harbin
The Second Affiliated Hospital of Nanchang University
RECRUITING
Jiangxi
Affiliated Cancer Hospital of Shandong First Medical University
RECRUITING
Jinan
The Second Affiliated Hospital of Kunming Medical University
RECRUITING
Kunming
Linyi Cancer Hospital
RECRUITING
Linyi
The First Affiliated Hospital of Nanchang University
RECRUITING
Nanchang
Jiangsu Cancer Hospital
RECRUITING
Nanjing
Fudan University Shanghai Cancer Center
RECRUITING
Shanghai
Shanghai Chest Hospital
RECRUITING
Shanghai
Shanghai East Hospital
RECRUITING
Shanghai
Shanxi Provincial Cancer Hospital
RECRUITING
Shanxi
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
RECRUITING
Shenzhen
Tianjin Medical University Cancer Institute & Hospital
RECRUITING
Tianjin
Weifang No.2 People's Hospital
RECRUITING
Weifang
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
RECRUITING
Wuhan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITING
Xi'an
The First Affiliated Hospital of Xiamen University
RECRUITING
Xiamen
The First Affiliated Hospital of Xinxiang Medical University
RECRUITING
Xinxiang
Northern Jiangsu People's Hospital
RECRUITING
Yangzhou
Henan Provincial Cancer Hospital
RECRUITING
Zhengzhou
France
CHU Angers - Hôpital Larrey
RECRUITING
Angers
Centre Hospitalier Intercommunal de Créteil
RECRUITING
Créteil
CHU Grenoble Alpes - Hopital Albert Michallon
RECRUITING
La Tronche
Hôpital Lyon Sud - Hospices Civils de Lyon
RECRUITING
Lyon
Assistance Publique - Hopitaux de Marseille, Hopital Nord
RECRUITING
Marseille
Hopital Tenon - Assistance Publique Hopitaux de Paris
RECRUITING
Paris
Institut Curie
RECRUITING
Paris
Hopital Haut-Leveque
RECRUITING
Pessac
CHU Rennes - Hopital Pontchaillou
RECRUITING
Rennes
Centre Hospitalier Universitaire de Nantes
RECRUITING
Saint-herblain
Hopital Saint Joseph - Paris
RECRUITING
Saint-mandé
CHU Strasbourg - Nouvel Hopital Civil
RECRUITING
Strasbourg
Germany
Augusta-Kranken-Anstalt gGmbH, Klinik f. Haematologie u. internistische Onkologie
RECRUITING
Bochum
Klinikum Chemnitz gGmbH
RECRUITING
Chemnitz
Klinikum Esslingen GmbH, Klinik fur Kardiologie, Angiologie and Pneumologie
RECRUITING
Esslingen Am Neckar
Katholisches Marienkrankenhaus gGmbH
RECRUITING
Hamburg
UKE Hamburg-Eppendorf fur Onkologie
RECRUITING
Hamburg
Johannes Wesling Klinikum Minden
RECRUITING
Minden
Greece
Anticancer-Oncology Hospital of Athens 'Agios Sawas' 1st Pathology-Oncology Department
RECRUITING
Athens
Henry Dunant Hospital Center, 4th Oncology Clinic
RECRUITING
Athens
Metropolitan Hospital
RECRUITING
Athens
University General Hospital of Larissa Department of Medical Oncology
RECRUITING
Larissa
University General Hospital of Patras, Division of Oncology
RECRUITING
Rio
Interbalkan Hospital of Thessaloniki
RECRUITING
Thessaloniki
St Luke's Hospital Oncology Department, Panorama
RECRUITING
Thessaloniki
Hungary
Bacs-Kiskun Varmegyei Oktatokorhaz, Onkoradiologiai Kozpont
RECRUITING
Kecskemét
Israel
Soroka Medical Center
RECRUITING
Beersheba
Rambam Health Care Campus
RECRUITING
Haifa
Hadassah Medical Center
RECRUITING
Jerusalem
Meir Medical Center
RECRUITING
Kfar Saba
Galilee Medical Center
RECRUITING
Naharyia
Italy
Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
RECRUITING
Aviano
IRCCS Candiolo - Istituto di Ricerca
RECRUITING
Candiolo
Ospedale San Luca - Lucca
RECRUITING
Lucca
ASST - Grande Ospedale Metropolitano Niguarda
RECRUITING
Milan
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
RECRUITING
Naples
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples
RECRUITING
Naples
Azienda Sanitaria Territoriale Pesaro e Urbino (AST)
RECRUITING
Pesaro
Casa di cura Pederzoli
RECRUITING
Peschiera Del Garda
Istituti di Ricovero e Cura A Carattere Scientifico - Istituti Fisioterapici Ospitalieri
RECRUITING
Roma
Universita Cattolica del Sacro Cuore
RECRUITING
Roma
Japan
Nagoya University Hospital
RECRUITING
Aichi
Shikoku Cancer Center
RECRUITING
Ehime
Kurume University Hospital
RECRUITING
Fukuoka
Kyushu University Hospital
RECRUITING
Fukuoka
Hiroshima City Hiroshima Citizens Hospital
RECRUITING
Hiroshima
Hyogo Cancer Center
RECRUITING
Hyōgo
Kanagawa Cancer Center
RECRUITING
Kanagawa
Kobe City Medical Center General Hospital
RECRUITING
Kobe
Sendai Kousei Hospital
RECRUITING
Miyagi
Niigata University Medical & Dental Hospital
RECRUITING
Nigata-shi
Okayama University Hospital
RECRUITING
Okayama
Kansai Medical University Hospital
RECRUITING
Osaka
Kindai University Hospital
RECRUITING
Osaka
National Hospital Organization Kinki Chuo Chest Medical Center
RECRUITING
Osaka
Osaka City General Hospital
RECRUITING
Osaka
Saitama Prefectural Cancer Center
RECRUITING
Saitama
Juntendo University School of Medicine Juntendo Clinic
RECRUITING
Tokyo
Nippon Medical School (all Hospitals)
RECRUITING
Tokyo
The Cancer Institute Hospital of JFCR
RECRUITING
Tokyo
Malaysia
Pantai Hospital Kuala Lumpur
RECRUITING
Kuala Lumpur
Beacon Hospital
RECRUITING
Kuala Selangor
Sunway Medical Centre
RECRUITING
Kuala Selangor
Sarawak General Hospital
RECRUITING
Kuching
University Malaya Medical Centre
RECRUITING
Lembah Pantai
Netherlands
Amsterdam UMC, Locatie VUMC
RECRUITING
Amsterdam
Zuyderland Medisch Centrum
RECRUITING
Heerlen
Frisius MC location Leeuwarden
RECRUITING
Leeuwarden
Maastricht University Medical Center
RECRUITING
Maastricht
Sint Antonius Ziekenhuis
RECRUITING
Utrecht
Norway
Haukeland University hospital
RECRUITING
Bergen
Seksjon for kreftbehandling, Drammen Hospital
RECRUITING
Drammen
Oslo University Hospital
RECRUITING
Oslo
Poland
Uniwersytet Medyczny w Lodzi
RECRUITING
Lodz
Poznan University of Medical Sciences
RECRUITING
Poznan
Podkarpackie Centrum Onkologii Rzeszow
RECRUITING
Rzeszów
Mazowiecki Szpital Wojewódzki im. św. Jana Pawła II w Siedlcach
RECRUITING
Siedlce
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Słupsku
RECRUITING
Stupsk
Republic of Korea
Samsung Changwon Hospital
RECRUITING
Changwon-si
Chonnam National University Hwasun Hospital
RECRUITING
Gwangju
Korea University Anam Hospital
RECRUITING
Seongbuk-gu
Seoul National University Bundang Hospital
RECRUITING
Seongnam
Asan Medical Center
RECRUITING
Seoul
Gyeongsang National University Hospital
RECRUITING
Seoul
Kangbuk Samsung Hospital
RECRUITING
Seoul
Samsung Medical Center
RECRUITING
Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital
RECRUITING
Seoul
Yonsei University Severance Hospital
RECRUITING
Seoul
The Catholic University of Korea, St. Vincent's Hospital
RECRUITING
Suwon
Ulsan University Hospital
RECRUITING
Ulsan
Romania
Spitalul Clinic Coltea
RECRUITING
Bucharest
S.C Radiotherapy Center Cluj S.R.L
RECRUITING
Cluj-napoca
S.C Centrul de Oncologie S.F Nectarie SRL
RECRUITING
Craiova
Institul Regional de Oncologie lasi;
RECRUITING
Iași
S.C Ovidius Clinical Hospital S.R.L
RECRUITING
Ovidiu
Spitalul Municipal Ploiesti
RECRUITING
Ploieşti
S.C Oncomed S.R.L
RECRUITING
Timișoara
Spain
Complejo Hospitalario Universitario A Coruña
RECRUITING
A Coruña
CEIC - Hospital Clinic i Provincial de Barcelona
RECRUITING
Barcelona
Hospital de la Santa Creu i Sant Pau
RECRUITING
Barcelona
Hospital Universitari Vall d'Hebron
RECRUITING
Barcelona
ICO(Instituto Catalan de Oncologia) Badalona - Germans Trias i Pujol
RECRUITING
Barcelona
Institut Catala d'Oncologia Girona
RECRUITING
Girona
Complejo Hospitalario de Jaén
RECRUITING
Jaén
Complejo Hospitalario Universitario Insular Materno-Infantil
RECRUITING
Las Palmas De Gran Canaria
Facultad de Medicina. Universidad Complutense de Madrid
RECRUITING
Madrid
Hospital General Universitario Gregorio Maranon
RECRUITING
Madrid
Hospital Quironsalud Malaga
RECRUITING
Málaga
Hospital Universitario Virgen de Valme
RECRUITING
Seville
Hospital Universitario Virgen de Valme Sevilla
RECRUITING
Seville
Hospital Clínico Universitario de Valencia
RECRUITING
Valencia
Hospital Universitari i Politecnic La Fe
RECRUITING
Valencia
Taiwan
Changhua Christian Hospital
RECRUITING
Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITING
Kaohsiung City
Taichung Veterans General Hospital
RECRUITING
Taichung
National Cheng Kung University Hospital
RECRUITING
Tainan
Koo Foundation Sun Yat-Sen Cancer Center
RECRUITING
Taipei
National Taiwan University Cancer Center
RECRUITING
Taipei
Taipei Veterans General Hospital
RECRUITING
Taipei
Chang Gung Memorial Hospital, Linkou
RECRUITING
Taoyuan
United Kingdom
The Christie NHS Foundation Trust
RECRUITING
Manchester
Contact Information
Primary
Gilead Clinical Study Information Cente
GileadClinicalTrials@gilead.com
1-833-445-3230 (GILEAD-0)
Time Frame
Start Date: 2025-04-04
Estimated Completion Date: 2029-10
Participants
Target number of participants: 695
Treatments
Experimental: Treatment Group A: SG
Participants assigned to treatment group A will receive SG 10 mg/kg intravenous (IV) infusion on Days 1 and 8 of a 21-day cycle. Participants will receive study drug until progressive disease (PD), death, unacceptable toxicity, or another treatment discontinuation criterion is met.
Experimental: Treatment Group B: Topotecan or Amrubicin (Japan only)
Participants assigned to treatment group B will receive Topotecan 1.5 mg/m\^2 daily on Days 1 to 5 of a 21-day cycle.~Japan participants assigned to treatment group B will have the option to receive Topotecan 1.5 mg/m\^2 daily on Days 1 to 5 of a 21-day cycle, or Amrubicin 40 mg/m\^2 daily on Days 1 to 3 of a 21-day cycle.~Participants will receive study drug until PD, death, unacceptable toxicity, or another treatment discontinuation criterion is met.
Related Therapeutic Areas
Sponsors
Leads: Gilead Sciences